Status:
COMPLETED
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Relapsing Remitting Multiple Sclerosis
Eligibility:
All Genders
15-60 years
Phase:
PHASE3
Brief Summary
Patient with relapsing remitting multiple sclerosis taking avonex are included in this double blind randomized control trial. Simvastatin is compared to placebo. end points of edss , total attack, new...
Eligibility Criteria
Inclusion
- edss\<5
- \>=1 attack in last year
Exclusion
- \>2 attacks in study
- drug complication
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00668343
Start Date
April 1 2005
End Date
March 1 2009
Last Update
July 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanaz Ahmadi
Tehran, Iran, 0098